In this study, researchers aimed to determine whether ctDNA is detectable in other bodily fluids besides blood, and to characterize any ctDNA they were able to detect.

Singaporean scientists have identified a possible early marker of Alzheimer's disease associated with disruption of the ...

The U.S. Food and Drug Administration (FDA) announced the recall of a specialty chocolate bar on Monday over concerns that ...

Ractigen Therapeutics is pleased to announce that the first patient has been dosed in the Phase II clinical trial of RAG-17, an innovative siRNA therapy targeting SOD1-mutated amyotrophic lateral ...

ESTEVE and TerSera Therapeutics LLC announced today that they have entered into an agreement in which ESTEVE will acquire ...

Supported by founding partners Michael and Susan Dell Foundation, Reliance Foundation and UBS Optimus Foundation, and led by Central Square Foundation and British Asian Trust, the initiative ...

In December 2025, pimicotinib was approved by the China National Medical Products Administration (NMPA) for the treatment of adult patients with symptomatic TGCT for which surgical resection will ...

As previously disclosed, the studies did not meet pre-specified co-primary, secondary, or exploratory biomarker endpoints The paper provides a ...

Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter, HKEX code: 02256.HK) announced today that the New Drug Application (NDA) for its novel, orally administered, highly selective, and ...

Human brains evolved under the steady pull of gravity, yet modern astronauts are spending months at a time in orbit, where ...

India AI Impact Summit 2026, Reliance Foundation, in partnership with Central Square Foundation, convened a high-level ...

Award highlights promise of ultrasound-based innovation in addressing unmet needs in dementia treatment SEOUL, South Korea, ...